Abstract
Specific pathogen-free (SPF) mice were treated with certain classes of immunosuppressive chemotherapeutic agents to determine if they would promote bacterial translocation from the gastrointestinal tract to the mesenteric lymph node, spleen, or liver. The antimetabolites methotrexate, 5-fluorouracil, and cytosine arabinoside were injected once intraperitoneally into SPF mice, and the mice were tested for bacterial translocation from the gastrointestinal tract. When total organs from the treated mice were compared with the total organs from the control mice, the alkylating agent cyclophosphamide promoted bacterial translocation when injected once intraperitoneally at doses of 100–400 mg/kg. Increasing the number of injections of cyclophosphamide did not increase the incidence of bacterial translocation. The steroid prednisone also promoted bacterial translocation after one intraperitoneal injection of 10–150 mg/kg. Prednisone and cyclophosphamide at various doses appeared to be more effective in promoting bacterial translocation from the gastrointestinal tract than the antimetabolites. The aerobic and facultatively anaerobic bacteria translocating to the various organs were identified asLactobacillus acidophilus, Escherichia coli, Klebsiella pneumoniae, Streptococcus faecalis, Staphylococcus aureus, andProteus mirabilis. Groups of SPF mice also were injected once intraperitoneally with the minimal dose of each chemotherapeutic drug that induced bacterial translocation, and then tested for immune responsiveness toE. coli vaccination. Each of the chemotherapeutic agents at the minimal doses promoting bacterial translocation also suppressed the serum antibody responses to antigens of indigenousE. coli. However, other toxic manifestations of these chemotherapeutic agents also may be involved in promoting bacterial translocation. The promotion of bacterial translocation from the gastrointestinal tract by these chemotherapeutic agents has important implications for the pathogenesis of infectious disease in patients receiving these drugs.
Similar content being viewed by others
Literature Cited
Altmann, G. G. 1974. Changes in the mucosa of the small intestine following methotrexate administration or abdominal X-irradiation. American Journal of Anatomy140:263–279.
Amaku, E. O., May, A. G., Hall, T. C., Linke, C. A. 1971. Prolongation of mouse skin allograft survival by treatment with cytosine arabinoside in combination with F-1 hydrid lymphocytes. Transplantation12:249–252.
Annana, A., Eloy, R., Bouchet, P., Clendinnen, G., Grenier, J. F. 1979. Effects of oral and parenteral corticosteroids on intestinal villous morphology and brush border enzymes in rats. Laboratory investigations41:83–88.
Baskerville, A., Batter-Hatton, D. 1977. Intestinal lesions induced experimentally by methotrexate. British Journal of Experimental Pathology58:663–669.
Berg, R. D. 1980. Inhibition ofEscherichia coli translocation from the gastrointestinal tract by normal cecal flora in gnotobiotic or antibiotic-decontaminated mice. Infection and Immunity29:1073–1081.
Berg, R. D. 1981. Promotion of the translocation of enteric bacteria from the gastrointestinal tract by oral treatment with penicillin, clindamycin or metronidazole. Infection and Immunity33:854–861.
Berg, R. D., Garlington, A. W. 1979. Translocation of certain indigenous bacteria from the gastrointestinal tract to the mesenteric lymph nodes and other organs in a gnotobiotic mouse model. Infection and Immunity23:403–411.
Berg, R. D., Garlington, A. W. 1980. Translocation ofEscherichia coli from the gastrointestinal tract to the mesenteric lymph nodes in gnotobiotic mice receivingEscherichia coli vaccines before colonization. Infection and Immunity30:894–898.
Berg, R. D., Owens, W. E. 1979. Inhibition of translocation of viableEscherichia coli from the gastrointestinal tract of mice by bacterial antagonism. Infection and Immunity25:820–827.
Bodey, G. P., McCredie, K. B., Rodriguez, V., Freireich, F. J. 1975. Management of infectious complications of cancer chemotherapy, pp. 357–368. In: Fundamental concepts and recent advances. Chicago: Yearbook Medical Publishers, Inc.
Buchanan, R. E., Gibbons, N. E. 1974. Bergey's manual of determinative bacteriology, 8th ed. Baltimore: The Williams and Wilkins Co.
Dubois, M., Gilles, K. A., Hamilton, J. K., Rebers, T. A., Smith, F. S. 1956. Colorimetric method of determination of sugars and related substances. Annals of Chemistry28:350–356.
Eloy, R., Vuitton, D., Vaultier, J.-P., Klein, M., Grenier, J. F. 1976. Cortisone sensitive T-cells in Peyer's patches. Experentia32:647–649.
Harrison, S. D., Denine, E. P., Peckham, J. C. 1978. Qualitative and quantitative toxicity of single and sequential sublethal doses of 5-fluorouracil in BDF1 mice. Cancer Treatment Reports62:533–545.
Hughes, W. T. 1977. Infections in the compromised host. Advances in Internal Medicine22:73–96.
Hurd, E. R. 1977. Drugs affecting the immune response, pp. 1067–1099. In: Holborow, E. J., Reeves, H. G. (eds.), Immunology in medicine.
Hyams, J. S., Donaldson, M. H. Metcalf, J. A., Root, R. K. 1978. Inhibition of human granulocyte function by methotrexate. Cancer Research38:650–655.
Jeyner, B. J., Altmann, G. G. 1978. Light and scanning electron microscopic observations of the effects of sublethal doses of methotrexate on the rat small intestines. Anatomical Record191:1–8.
Lane, M. 1959. Preliminary report of animal studies with cytoxan (cyclophosphamide). Cancer Chemotherapy Reports3:1–5.
Leach, W. B., Laster, Jr., W. R., Mayo, J. G., Griswold, Jr., D. P., Schabel, Jr., F. M. 1969. Toxicity studies in mice treated with 1-B-D-arabinofucanosylcytosine (ar-C). Cancer Research29:529–535.
Margolis, S., Phillips, F. S., Steinberg, S. S. 1971. The cytotoxicity of methotrexate in mouse small intestine in relation to inhibition of folic acid reductase and of DNA synthesis. Cancer Research31:2037–2046.
Merritt, K., Johnson, A. G. 1963. Studies on the adjuvant action of bacterial endotoxins on antibody formation. V. The influence of endotoxin and 5-fluoro-2-deoxyuridine on the primary antibody response of the BALB mouse to a purified protein antigen. Journal of Immunology91:266–272.
Muggia, A. L., Wayman, E., Miller, S. S., Spiro, H. M. 1963. Response of the gastrointestinal tract of the mouse to 5-fluorouracil. American Journal of Pathology42:407–414.
Owens, W. E., Berg, R. D. 1980. Inhibition by thymic grafts of bacterial translocation from the gastrointestinal tract in athymic (nu/nu) mice. Infection and Immunity27:461–467.
Owens, W. E., Berg, R. D. 1982. Bacterial translocation from the gastrointestinal tracts of thymectomized mice. Current Microbiology7:169–174.
Prierson, C. L., Johnson, A. G., Feller, I. 1976. Effect of cyclophosphamide on the immune response toPseudomonas aeruginosa in mice. Infection and Immunity14:168–177.
Salaman, J. R., Miller, J. J. 1979. Nonspecific chemical immunosuppression. Transplantation Proceedings11:845–850.
Schaedler, R. W., Dubos, R., Costello, R. 1965. The development of the bacterial flora in the gastrointestinal tract of mice. Journal of Experimental Medicine122:59–66.
Schreiber, A. D. 1977. Clinical immunology of the corticosteroids. Progress in Clinical Immunology4:103–114.
Sharbaugh, R. J., Grogan, J. B. 1969. Suppression of reticuloendothelial function in the rat with cyclophosphamide. Journal of Bacteriology100:117–122.
Siber, G. R., Mayer, R. J., Levin, M. J. 1980. Increased gastrointestinal absorption of large molecules in patients after 5-fluorouracil therapy from metastatic colon carcinoma. Cancer Research40:3430–3436.
Smith, P. B., Tomfohrd, K. M., Rhoden, D. L., Balows, A. 1972. API system: a multitube micromethod for identification ofEnterobacteriaceae. Applied Microbiology24:449–452.
Taminiau, J. A. J. M., Gall, D. G., Hamilton, J. R. 1980. Response of the rat small-intestine epithelium to methotrexate. Gut21:486–492.
Weir, D. M. 1967. Handbook of experimental immunology. Philadelphia: F. A. Davis Co.
Winkelstein, A. 1973. Differential effects of immunosuppressants on lymphocyte function. Journal of Clinical Investigation52:2293–2299.
Woodruff, R. 1978. The management of adult acute lymphoblastic leukaemia. Cancer Treatment Reviews5:95–113.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Berg, R.D. Bacterial translocation from the gastrointestinal tracts of mice receiving immunosuppressive chemotherapeutic agents. Current Microbiology 8, 285–292 (1983). https://doi.org/10.1007/BF01577729
Issue Date:
DOI: https://doi.org/10.1007/BF01577729